Cyclosporine Neoral in renal transplant recipients: impact on hepatic dysfunction.
Bakr
M A
MA
Urology & Nephrology Center, Mansoura University, Egypt.
Refaie
A
A
Mekresh
M
M
Ihab
M H
MH
Sobh
M
M
Ghoneim
M A
MA
D000284:Administration, Oral; D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D016572:Cyclosporine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004655:Emulsions; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D008111:Liver Function Tests; D008875:Middle Aged
D004655:Emulsions; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin